8,11-Dichloro-5H-dibenzo[b,e][1,4]diazepine EINECS 200-795-6 H-Trp-OH L(-)-Tryptophan L-Trp-OH L-TRYPTOPHAN (13C11,D8,15N2) L-Tryptophan(pharm grade) L-Tryptophan, Animal-Free L-Tryptophan, Trp MFCD00064340 Tadalafil Impurity 2 Trytophan (W) Solution, 100ppm VWR SURFACE SAMPLING SPONGE WITH NE
NCI Carcinogenesis Bioassay (feed); No Evidence: mouse, rat NCITR* ?? National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD 20014) No. NCI-CG-TR-71 ,1978. . Reported in EPA TSCA Inventory.
Moderately toxic by intraperitoneal route. Experimental teratogenic and reproductive effects. Human mutation data reported. Questionable carcinogen with experimental tumorigenic data. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes?of L-Tryptophan (CAS NO.73-22-3):?Xi
Risk Statements: 33-40-62-41-37/38-36/37/38-22
R33: Danger of cumulative effects.?
R40: Limited evidence of a carcinogenic effect.?
R62: Risk of impaired fertility.?
R41: Risk of serious damage to the eyes.?
R37/38: Irritating to respiratory system and skin.?
R36/37/38: Irritating to eyes, respiratory system and skin.?
R22: Harmful if swallowed.
Safety Statements: 24/25-36/37/39-36-26
S24/25: Avoid contact with skin and eyes.?
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.?
S36: Wear suitable protective clothing.?
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany: 2
RTECS: YN6130000
F: 8
HS Code: 29339990
? L-Tryptophan , with CAS number of 73-22-3, can be called (S)-alpha-Amino-1H-indole-3-propanoic acid ; (S)-alpha-Aminoindole-3-propionic acid ; 1-beta-3-Indolylalanine ; 1H-Indole-3-alanine (VAN) ; 1H-Indole-3-propanoic acid, alpha-amino-, (S)- ; 2-Amino-3-indolylpropanoic acid . It is a?white to off-white crystalline powder.?L-Tryptophan (CAS NO.73-22-3) are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
bird - domestic | LD50 | intraperitoneal | 2410mg/kg (2410mg/kg) | ? | Drugs in Japan Vol. -, Pg. 744, 1990. |
man | TDLo | oral | 300mg/kg (300mg/kg) | BEHAVIORAL: EXCITEMENT BEHAVIORAL: ANTIANXIETY |
British Medical Journal. Vol. 2, Pg. 701, 1976. |
man | TDLo | oral | 857mg/kg/30D- (857mg/kg) | BLOOD: EOSINOPHILIA SKIN AND APPENDAGES (SKIN): OTHER GLANDS: OTHER MUSCULOSKELETAL: OTHER CHANGES |
New England Journal of Medicine. Vol. 322, Pg. 874, 1990. |
mouse | LD50 | intraperitoneal | 4800mg/kg (4800mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980. |
mouse | LDLo | oral | 15gm/kg (15000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980. |
rat | LD50 | intraperitoneal | 1634mg/kg (1634mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Archives of Biochemistry and Biophysics. Vol. 58, Pg. 253, 1955. |
rat | LD50 | oral | > 16gm/kg (16000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: COMA |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980. |
rat | LDLo | unreported | 2553mg/kg (2553mg/kg) | ? | Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 884, 1973. |
women | TDLo | oral | 2700mg/kg/13W (2700mg/kg) | LUNGS, THORAX, OR RESPIRATION: STRUCTURAL OR FUNCTIONAL CHANGE IN TRACHEA OR BRONCHI LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA BLOOD: EOSINOPHILIA |
Annals of Internal Medicine. Vol. 112, Pg. 301, 1990. |
women | TDLo | oral | 3276mg/kg/9W- (3276mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BLOOD: EOSINOPHILIA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Annals of Internal Medicine. Vol. 112, Pg. 344, 1990. |
women | TDLo | oral | 4800mg/kg/34W (4800mg/kg) | PERIPHERAL NERVE AND SENSATION: PARESTHESIS SKIN AND APPENDAGES (SKIN): OTHER GLANDS: OTHER BLOOD: EOSINOPHILIA |
New England Journal of Medicine. Vol. 322, Pg. 874, 1990. |
women | TDLo | oral | 5400mg/kg/134 (5400mg/kg) | BLOOD: EOSINOPHILIA SKIN AND APPENDAGES (SKIN): OTHER GLANDS: OTHER |
New England Journal of Medicine. Vol. 322, Pg. 874, 1990. |
women | TDLo | oral | 9gm/kg/22W-I (9000mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LIVER: LIVER FUNCTION TESTS IMPAIRED BLOOD: EOSINOPHILIA |
Annals of Internal Medicine. Vol. 112, Pg. 957, 1990. |
women | TDLo | oral | 10960mg/kg/20 (10960mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA BLOOD: EOSINOPHILIA |
British Medical Journal. Vol. 301, Pg. 21, 1990. |
Not classified.
Pictogram(s) | No symbol. |
---|---|
Signal word | No signal word. |
Hazard statement(s) | none |
Precautionary statement(s) | |
Prevention | none |
Response | none |
Storage | none |
Disposal | none |
none